Accidental transplantation of a kidney with a cystic renal cell carcinoma following living donation: Management and 1 yr follow-up

Clinical Transplantation

Volumn 20, Issue 2, 2006, Pages 147-150

  Neipp, Michael ^a   Schwarz, Anke ^a   Pertschy, Stefanie ^a   Klempnauer, Jürgen ^a   Becker, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Kidney transplantation; Living donation; Outcome; Partial nephrectomy; Tumor transmission

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN;

ADULT; ARTICLE; CANCER TRANSPLANTATION; CASE REPORT; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; IATROGENIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CARCINOMA; KIDNEY EXAMINATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVING DONOR; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL ERROR; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; TUMOR RECURRENCE;

ADULT; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY DISEASES, CYSTIC; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MEDICAL ERRORS; MIDDLE AGED; NEPHRECTOMY; PERITONEAL DIALYSIS; TREATMENT OUTCOME;

EID: 33646021892     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00455.x     Document Type: Article

References (19)

1. Penn I. Primary kidney tumors before and after renal transplantation. Transplantation 1995: 59: 480.
2. Detry O, De Roover A, de Leval L et al. Transmission of an undiagnosed sarcoma to recipients of kidney and liver grafts procured in a non-heart beating donor. Liver Transpl 2005: 11: 696.
3. Buell JF, Trofe J, Hanaway MJ et al. Transmission of donor cancer into cardiothoracic transplant recipients. Surgery 2001: 130: 660.
4. Stephens JK, Everson GT, Elliott CL et al. Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation 2000: 70: 232.
5. Morris-Stiff G, Steel A, Savage P et al. Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant 2004: 4: 444.
6. Gerstenkorn C, Thomusch O. Transmission of a pancreatic adenocarcinoma to a renal transplant recipient. Clin Transplant 2003: 17: 473.
7. Neipp M, Jackobs S, Becker T et al. Living donor nephrectomy: Flank incision versus anterior vertical mini-incision. Transplantation 2004: 78: 1356.
8. Nassir A, Jollimore J, Gupta R, Bell D, Norman R. Multilocular cystic renal cell carcinoma: A series of 12 cases and review of the literature. Urology 2002: 60: 421.
9. Han KR, Janzen NK, McWhorter VC et al. Cystic renal cell carcinoma: biology and clinical behavior. Urol Oncol 2004: 22: 410.
10. Matin SF, Gill IS, Worley S, Novick AC. Outcome of laparoscopic radical and open partial nephrectomy for the sporadic 4 cm or less renal tumor with a normal contralateral kidney. J Urol 2002: 168: 1356.
11. Allaf ME, Bhayani SB, Rogers C et al. Laparoscopic partial nephrectomy: evaluation of long-term oncological outcome. J Urol 2004: 172: 871.
12. Kim JY, Ruckle HC, Ramin SA. Partial nephrectomy for renal cell carcinoma in an allograft kidney 15 years after transplantation. J Urol 2001: 165: 1205.
13. Thomalla JV. Renal cell carcinoma in a renal allograft successful treatment with 5 year follow-up. Clin Med Res 2004: 2: 151.
14. Lamb GW, Baxter GM, Rodger RS, Aitchison M. Partial nephrectomy used to treat renal cell carcinoma arising in a live donor transplant kidney. Urol Res 2004: 32: 89.
15. Luan FL, Hojo M, Maluccio M, Yamaji K, Suthanthiran M. Rapamycin blocks tumor progression: Unlinking immunosuppression from antitumor efficacy. Transplantation 2002: 73: 1565.
16. Luan FL, Ding R, Sharma VK, Chon WJ, Lagman M, Suthanthiran M. Rapamycin is an effective inhibitor of human renal cancer metastasis. Kidney Int 2003: 63: 917.
17. Campistol JM, Gutierrez-Dalmau A, Torregrosa JV. Conversion to sirolimus: A successful treatment for posttransplantation Kaposi's sarcoma. Transplantation 2004: 77: 760.
18. Stallone G, Schena A, Infante B et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 2005: 352: 1317.
19. Kneteman NM, Oberholzer J, Al Saghier M et al. Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Liver Transpl 2004: 10: 1301.